Gold Supply Shock: The Race for Production-Ready Assets
VANCOUVER, British Columbia, Feb. 05, 2026 — EquityInsider.com News Commentary — The easy money in exploration is gone; the smart money is moving into execution. Investors are waking up to a massive shift as permitting reforms finally compress the regulatory timelines that used to strangle development[1]. Governments are simultaneously accelerating approvals to secure critical domestic supply chains[2]. […]
$207B Market Shift: The Race for Fast Track Approval in Oncology
Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Feb. 5, 2026 — USANewsGroup.com News Commentary – The FDA isn’t just approving drugs; they are completely reshaping the landscape. In 2025 alone, the agency issued over 50 oncology approvals[1], but the real story is the aggressive pivot toward targeted therapies for high-unmet-need solid tumors. That momentum has accelerated in […]